Search Results

Hepatitis B therapies and antiviral resistance detection and management

Authors: Holness, Giselle; Carriero, Damaris C; Dieterich, Douglas T

Source: Expert Review of Gastroenterology and Hepatology, Volume 3, Number 6, December 2009 , pp. 693-699(7)

Publisher: Expert Reviews

Development of a Practical Method for Using Ozone Gas as a Virus Decontaminating Agent

Authors: Hudson, James; Sharma, Manju; Vimalanathan, Selvarani

Source: Ozone: Science and Engineering, Volume 31, Number 3, May 2009 , pp. 216-223(8)

Publisher: Taylor and Francis Ltd

Entecavir for the long-term treatment of chronic hepatitis B

Authors: Gonzalez, Stevan A; Keeffe, Emmet B

Source: Expert Review of Anti-Infective Therapy, Volume 7, Number 9, November 2009 , pp. 1053-1062(10)

Publisher: Expert Reviews

Effects of chlorophyllin on replication of poliovirus and bovine herpesvirus in vitro

Authors: Benati, F.J.; Lauretti, F.; Faccin, L.C.; Nodari, B.; Ferri, D.V.; Mantovani, M.S.; Linhares, R.E.C.; Nozawa, C.

Source: Letters in Applied Microbiology, Volume 49, Number 6, December 2009 , pp. 791-795(5)

Publisher: Blackwell Publishing

Enterovirus 71: epidemiology, pathogenesis and management

Authors: Wang, Shih-Min; Liu, Ching-Chuan

Source: Expert Review of Anti-Infective Therapy, Volume 7, Number 6, August 2009 , pp. 735-742(8)

Publisher: Expert Reviews

Valganciclovir in Adult Solid Organ Transplant Recipients: Pharmacokinetic and Pharmacodynamic Characteristics and Clinical Interpretation of Plasma Concentration Measurements

Authors: Perrottet, Nancy; Decosterd, Laurent A.; Meylan, Pascal; Pascual, Manuel; Biollaz, Jerome; Buclin, Thierry

Source: Clinical Pharmacokinetics, Volume 48, Number 6, 6 June 2009 , pp. 399-418(20)

Publisher: Adis International

Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients

Authors: Vandekerckhove, Linos; Verhofstede, Chris; Vogelaers, Dirk

Source: Journal of Antimicrobial Chemotherapy, Volume 63, Number 6, 30 June 2009 , pp. 1087-1096(10)

Publisher: Oxford University Press

The αGal HyperAcute^® Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural αGal-Mediated Zoonotic Blockade

Authors: Mandell, R. B.; Flick, R.; Staplin, W. R.; Kaniewski, L. D.; Carzoli, A. K.; Manuszak, R. P.; Wang, J.; Rossi, G. R.; Vahanian, N. N.; Link, C. J.

Source: Zoonoses and Public Health, Volume 56, Numbers 6-7, August 2009 , pp. 391-406(16)

Publisher: Blackwell Publishing

Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C

Author: Rustgi, Vinod K.

Source: Current Medical Research and Opinion, Volume 25, Number 4, April 2009 , pp. 991-1002(12)

Publisher: Informa Healthcare

Fluorescence Study on the Interaction Between Hypericin and Lens Protein “α-Crystallin”

Author: Youssef, Tareq

Source: Photochemistry and Photobiology, Volume 85, Number 4, July/August 2009 , pp. 921-926(6)

Publisher: Blackwell Publishing

A Review on Extraction, Synthesis and Anticancer Activity of Betulinic Acid

Authors: Tripathi, Laxmi; Kumar, Praveen; Singh, Ranjit

Source: Current Bioactive Compounds, Volume 5, Number 2, June 2009 , pp. 160-168(9)

Publisher: Bentham Science Publishers

Oseltamivir for treatment and prophylaxis of influenza infection

Authors: Schirmer, Patricia; Holodniy, Mark

Source: Expert Opinion on Drug Safety, Volume 8, Number 3, May 2009 , pp. 357-371(15)

Publisher: Informa Healthcare

Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model

Authors: Kim, J.; Lee, C.; Chong, Y.

Source: SAR and QSAR in Environmental Research, Volume 20, Numbers 1-2, January 2009 , pp. 103-118(16)

Publisher: Taylor and Francis Ltd

Drug Targets in Hepatitis B Virus Infection

Authors: Stein, Lance L.; Loomba, Rohit

Source: Infectious Disorders - Drug Targets(Formerly Current Drug Targets - Infectious Disorders), Volume 9, Number 2, April 2009 , pp. 105-116(12)

Publisher: Bentham Science Publishers

Advances in Interleukin-12 Gene Therapy for Acquired Liver Diseases

Authors: Berraondo, Pedro; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria

Source: Current Gene Therapy, Volume 9, Number 2, April 2009 , pp. 62-71(10)

Publisher: Bentham Science Publishers

Taribavirin: a potential alternative to ribavirin

Authors: Poordad, Fred F; Chee, Grace

Source: Future Virology, Volume 4, Number 2, March 2009 , pp. 113-120(8)

Publisher: Future Medicine

A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections

Authors: Yang, Yang; Halloran, M. Elizabeth; Longini, Ira M.

Source: Biostatistics, Volume 10, Number 2, 8 April 2009 , pp. 390-403(14)

Publisher: Oxford University Press

Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model

Authors: Sander, Beate; Nizam, Azhar; Garrison, Louis P.; Postma, Maarten J.; Halloran, M. Elizabeth; Longini, Ira M.

Source: Value in Health, Volume 12, Number 2, March/April 2009 , pp. 226-233(8)

Publisher: Blackwell Publishing

The use of oseltamivir during an influenza B outbreak in a chronic care hospital

Authors: Seale, Holly; Weston, Kathryn M.; Dwyer, Dominic E.; Zhu, Mengzhi; Allchin, Lisa; Booy, Robert; Raina MacIntyre, C.

Source: Influenza and Other Respiratory Viruses, Volume 3, Number 1, January 2009 , pp. 15-20(6)

Publisher: Blackwell Publishing

Treatment of HBeAg-positive patients with nucleos/tide analogues

Authors: Coffin, Carla S.; Lee, Samuel S.

Source: Liver International, Volume 29, Supplement 1, January 2009 , pp. 116-124(9)

Publisher: Blackwell Publishing